Research programme: antibacterials - TevaAlternative Names: TV-7130
Latest Information Update: 12 Aug 2011
At a glance
- Originator Teva Pharmaceutical Industries
- Class Amino acids; Peptides
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Septic shock
Most Recent Events
- 16 Nov 2006 Preclinical trials in Septic shock in Israel (IV)